SCHEMBL7896798

SCHEMBL7896798

Nc1ccccc1NS(=O)(=O)c1cccc2cccnc12

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC40A1 Q9NP59 12/20 0.80
▸ MEN1 O00255 5/20 0.80
▸ KMT2A Q03164 5/20 0.80
▸ TDP1 Q9NUW8 5/20 0.80
▸ NFKBIA P25963 3/20 0.80
▸ RELA Q04206 2/20 0.80
▸ GAA P10253 2/20 0.71
▸ ALDH1A1 P00352 2/20 0.67
▸ POLB P06746 1/20 0.67
▸ MMP2 P08253 1/20 0.60
▸ MDM4 O15151 1/20 0.58
▸ OPRK1 P41145 1/20 0.58
▸ MDM2 Q00987 1/20 0.58
▸ G6PD P11413 1/20 0.58
▸ AGTR1 P30556 1/20 0.58
▸ METAP2 P50579 1/20 0.58
▸ METAP1 P53582 1/20 0.58
▸ GLO1 Q04760 1/20 0.58
▸ PAX8 Q06710 1/20 0.58
▸ ATM Q13315 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL460773 0.89 SLC40A1 (1.00) SLC40A1MEN1KMT2ATDP1NFKBIA
SCHEMBL31676665 0.89 SLC40A1 (1.00) SLC40A1MEN1KMT2ATDP1NFKBIA
SCHEMBL1507919 0.87 SLC40A1 (0.76) SLC40A1MEN1KMT2ATDP1NFKBIA
SCHEMBL30854809 0.87 SLC40A1 (0.76) SLC40A1MEN1KMT2ATDP1NFKBIA
SCHEMBL3780950 0.86 GAA (0.76) SLC40A1MEN1KMT2ATDP1NFKBIA
SCHEMBL14919826 0.83 GAA (0.71) SLC40A1MEN1KMT2ATDP1NFKBIA
SCHEMBL29540765 0.83 GAA (0.71) SLC40A1MEN1KMT2ATDP1NFKBIA
SCHEMBL22234047 0.83 GAA (0.71) SLC40A1MEN1KMT2ATDP1NFKBIA
SCHEMBL30925552 0.82 SLC40A1 (0.78) SLC40A1MEN1KMT2ATDP1NFKBIA
SCHEMBL27214248 0.82 SLC40A1 (0.78) SLC40A1MEN1KMT2ATDP1NFKBIA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6180675-B1 THERAPY FOR CHEMOKINE SENSITIVE DISEASE; USING A AROMATIC (THIO)UREA COMPOUND SMITHKLINE BEECHAM CORPORATION 2001-01-30 — — US disclosed
Send feedback